Summary

Executive Summary

According to Azoth Analytics research report, the Global Antibiotic Market was valued at USD 46.66 Billion in the year 2020 with North America leading the regional market share. Growth in the Antibiotics Market is mainly driven by the growth of the ageing population, rising technical advancements and increasing awareness of infectious diseases in the global platform. Growing awareness, as well as investments in the development of new antibiotics in the market, is pushing the research and development as well as clinical trials in the world.

Moreover, the trend towards excessive use of antibiotics by the people is putting the risk of growing antimicrobial resistance amongst the citizens which will make the present antibiotics ineffective against disease-causing bacteria. This is forcing the world to focus more on improving the clinical research on new antibiotics in the world. With population growth and the rising geriatric population, there will be more demand for antibiotics which will push the global antibiotics market even further.

With the outbreak of the virus, as much as 95% of the people were prescribed antibiotics for their treatment. These included azithromycin, hydroxychloroquine (a chloroquine derivative of antimalarial drug) among others which proved successful for the treatment of virus during uncertain times. Many people avoided staying in the hospitals for a longer duration during the pandemic, thus prescribing antibiotics seemed the only way out. With more patients getting prescribed antibiotics, there was an increase in the demand for the same and the antibiotics market faced supply chain shortages.

Scope of the Report

• The report presents the analysis of the Antibiotics market for the historical period of 2016-2020 and the forecast period of 2021-2026.
• The report analyses the Antibiotics Market by Value (USD Billion).
• The report analyses the Antibiotics Market by Drug Class (Beta-Lactams (Penicillin), Cephalosporins, Lipopeptide, Others).
• The report analyses the Antibiotics Market by Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis, Others).
• The Global Antibiotics Market has been analysed By Region (North America, Europe, Asia Pacific, LAMEA).
• The Global Antibiotics Market has been analysed By Country (United States, Canada, Germany, France, United Kingdom, Spain, Italy, China, Japan, India).
• The attractiveness of the market has been presented by region, by Drug Class and by Mechanism.
• Also, the major opportunities, trends, drivers and challenges of the industry have been analysed in the report.
• The report tracks competitive developments, strategies, mergers and acquisitions and product pipeline.
• The companies analysed in the report include DEINOVE, Bayer Group, Pfizer Inc., GlaxoSmithKline, Novartis AG, Eli Lilly and Company, Roche Holding AG, Amgen Inc., Johnson & Johnson and Merck KGaA.

Key Target Audience

• Antibiotics Manufacturers
• Healthcare and Pharmaceutical Companies
• Consulting and Advisory Firms
• Government and Policy Makers
• Regulatory Authorities

ページTOPに戻る

Table of Contents

1. Report Scope and Methodology
1.1 Scope of the Report
1.2 Research Methodology
1.3 Executive Summary

2. Strategic Recommendations

3. Antibiotics Market: Product Outlook

4. Global Antibiotics Market: Sizing and Forecast
4.1 Global Antibiotics Market Size, By Value, 2016-2026

5. Global Antibiotics Market Segmentation – By Drug Class, By Mechanism
5.1 Competitive Scenario of Global Antibiotics Market: By Drug Class
5.1.1 Beta-Lactams (Penicillin) – Market Size and Forecast (2016-2026)
5.1.2 Cephalosporins– Market Size and Forecast (2016-2026)
5.1.3 Lipopeptides – Market Size and Forecast (2016-2026)
5.1.4 Others – Market Size and Forecast (2016-2026)
5.2 Competitive Scenario of Global Antibiotics Market: By Mechanism
5.2.1 Cell Wall Synthesis – Market Size and Forecast (2016-2026)
5.2.2 Protein – Market Size and Forecast (2016-2026)
5.2.3 DNA Synthesis – Market Size and Forecast (2016-2026)
5.2.4 Others – Market Size and Forecast (2016-2026)

6. Global Antibiotics Market: Regional Analysis
6.1 Competitive Scenario of Global Antibiotics Market: By Region

7. North America Antibiotics Market: An Analysis (2016-2026)

7.1 North America Antibiotics Market: Size and Forecast (2016-2026)
7.2 North America Antibiotics Market – Prominent Companies
7.3 Market Segmentation By Drug Class (Beta-Lactams (Penicillin), Cephalosporins, Lipopeptides and Others)
7.4 Market Segmentation By Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis and Others)
7.5 North America Antibiotics Market: Country Analysis
7.6 Market Opportunity Chart of North America Antibiotics Market - By Country, By Value, 2026
7.7 Competitive Scenario of North America Antibiotics Market: By Country
7.8 United States Antibiotics Market: Size and Forecast (2016-2026), By Value
7.9 United States Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
7.10 Canada Antibiotics Market: Size and Forecast (2016-2026), By Value
7.11 Canada Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)

8. Europe Antibiotics Market: An Analysis (2016-2026)

8.1 Europe Antibiotics Market: Size and Forecast (2016-2026), By Value
8.2 Europe Antibiotics Market – Prominent Companies
8.3 Market Segmentation By Drug Class (Beta-Lactams (Penicillin), Cephalosporins, Lipopeptides and Others)
8.4 Market Segmentation By Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis and Others)
8.5 Europe Antibiotics Market: Country Analysis
8.6 Market Opportunity Chart of Europe Antibiotics Market - By Country, By Value, 2026
8.7 Competitive Scenario of Europe Antibiotics Market: By Country
8.8 Germany Antibiotics Market: Size and Forecast (2016-2026), By Value
8.9 Germany Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
8.10 United Kingdom Antibiotics Market: Size and Forecast (2016-2026), By Value
8.11 United Kingdom Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
8.12 France Antibiotics Market: Size and Forecast (2016-2026), By Value
8.13 France Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
8.14 Spain Antibiotics Market: Size and Forecast (2016-2026), By Value
8.15 Spain Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
8.16 Italy Antibiotics Market: Size and Forecast (2016-2026), By Value
8.17 Italy Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)

9. Asia Pacific Antibiotics Market: An Analysis (2016-2026)

9.1 Asia Pacific Antibiotics Market: Size and Forecast (2016-2026), By Value
9.2 Asia Pacific Antibiotics Market – Prominent Companies
9.3 Market Segmentation By Drug Class (Beta-Lactams (Penicillin), Cephalosporins, Lipopeptides and Others)
9.4 Market Segmentation By Mechanism (Cell Wall Synthesis, Protein Synthesis, DNA Synthesis and Others)
9.5 Asia Pacific Antibiotics Market: Country Analysis
9.6 Market Opportunity Chart of Asia Pacific Antibiotics Market - By Country, By Value, 2026
9.7 Competitive Scenario of Asia Pacific Antibiotics Market: By Country
9.8 China Antibiotics Market: Size and Forecast (2016-2026), By Value
9.9 China Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
9.10 Japan Antibiotics Market: Size and Forecast (2016-2026), By Value
9.11 Japan Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)
9.12 India Antibiotics Market: Size and Forecast (2016-2026), By Value
9.13 India Antibiotics Market Segmentation - By Drug Class, By Mechanism (2016-2026)

10. Global Antibiotics Market Dynamics
10.1 Drivers
10.2 Restraints
10.3 Trends

11. Market Attractiveness
11.1 Market Attractiveness Chart of Global Antibiotics Market – By Drug Class, 2026
11.2 Market Attractiveness Chart of Global Antibiotics Market - By Mechanism, 2026
11.3 Market Attractiveness Chart of Global Antibiotics Market - By Region, 2026

12. Competitive Landscape
12.1 Major Technological Innovations, Mergers & Acquisitions and Role of Manufacturers
12.2 Product Pipeline of Leading Antibiotic Companies
12.3 Market Share Analysis

13. Company Analysis
13.1 DEINOVE
13.2 Bayer Group
13.3 Pfizer Inc.
13.4 GlaxoSmithKline
13.5 Novartis AG
13.6 Eli Lily and Company
13.7 Roche Holding AG
13.8 Amgen Inc.
13.9 Johnson & Johnson
13.10 Merck KGaA